Champions Oncology, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSBR research report →
Companywww.championsoncology.com
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
- CEO
- Robert Brainin
- IPO
- 2007
- Employees
- 210
- HQ
- Hackensack, NJ, US
Price Chart
Valuation
- Market Cap
- $84.02M
- P/E
- -37.34
- P/S
- 1.45
- P/B
- 19.62
- EV/EBITDA
- -91.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 43.37%
- Op Margin
- -3.84%
- Net Margin
- -3.88%
- ROE
- -57.20%
- ROIC
- -23.16%
Growth & Income
- Revenue
- $56.94M · 13.54%
- Net Income
- $4.70M · 164.61%
- EPS
- $0.34 · 162.96%
- Op Income
- $4.85M
- FCF YoY
- 200.34%
Performance & Tape
- 52W High
- $9.63
- 52W Low
- $5.50
- 50D MA
- $5.96
- 200D MA
- $6.47
- Beta
- 0.43
- Avg Volume
- 8.73K
Get TickerSpark's AI analysis on CSBR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 16, 25 | Brainin Robert Lawrence | other | 100,000 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 100,000 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 150,000 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 62,500 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 62,500 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 225,000 |
| Nov 12, 24 | Brainin Robert Lawrence | other | 23,030 |
| Nov 3, 23 | Brainin Robert Lawrence | other | 19,070 |
| Nov 1, 22 | Brainin Robert Lawrence | other | 14,130 |
| Nov 5, 21 | Brainin Robert Lawrence | other | 9,901 |
Our CSBR Coverage
We haven't published any research on CSBR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CSBR Report →